Respiratory Syncytial Virus Disease in Infants Despite Prior Administration of Antigenic Inactivated Vaccine
This article, published in the American Journal of Epidemiology, details studies conducted to determine the ability of a formalin inactivated vaccine candidate to protect against respiratory syncytial virus (RSV) disease. Results from the study showed a lack of protection against natural RSV infection in infants receiving the vaccine, as well as an association with enhancing illness among infants naturally infected with RSV after being vaccinated. ABSTRACT ONLY. (Learn how users in developing countries can gain free access to journal articles.)
Author: Kim HW, Canchola JG, Brandt CD, et al.
» Visit web page (English)
(Located at aje.oxfordjournals.org)
Citation: Kim HW, Canchola JG, Brandt CD, et al. Respiratory Syncytial Virus Disease in Infants Despite Prior Administration of Antigenic Inactivated Vaccine. American Journal of Epidemiology. 1969;89(4):422-434.
Resource types: Peer-reviewed journal
Diseases/vaccines: Respiratory syncytial virus (RSV)
Regions: North America and Europe